With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European approval Monday. With the FDA’s blessing, Albireo is kicking off an “immediate”… Read More »
A new side effect has been added to the official list for two Covid vaccines by the UK medicines watchdog. Heart inflammation has been linked to both the Pfizer and Moderna jabs in recent weeks after several cases were reported. And the Medicines and Healthcare products Regulatory Agency (MHRA) has now updated the safety information… Read More »
You’d think it would be simple to drop millions of dollars at a casino. But extracting that kind of dough tends to require a delicate dance between casino, player and host: the person charged with luring gamblers to bet big and lose big. It can involve private jets, exotic hotel suites, bottles of Cristal, Cuban… Read More »
Dive Brief: More than half of all commercial plan payments to hospitals in 2017 were earmarked toward some form of value-oriented care or alternative payments intended to reduce waste, according to the latest scorecard from Catalyst for Payment Reform (CPR) — up from just 10.2% in 2012. However, a large chunk of the value-oriented payment (90%) was… Read More »
By most accounts, Amina Abudu was a happy, healthy little girl in 2009, when health authorities declared that a pandemic flu virus was sweeping the world. A vaccine was rushed to market, and the five year old was among millions of Canadians to get the shot, amid widespread fears about the new pathogen. Five days… Read More »